ALVAC-MAGE-1/MAGE-3 skin cancer vaccine (Sanofi Pasteur)

N/A

Report date: 2022/03/03 17:33:54

Base Information

Drug NameALVAC-MAGE-1/MAGE-3 skin cancer vaccine (Sanofi Pasteur)

Drug Alias NameMAGE-1/MAGE-3 vaccine (ALVAC canarypox vector, melanoma)ALVAC-MAGE-1/MAGE-3melanoma vaccine (ALVAC-MAGE-1/MAGE-3)

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionMelanoma-associated antigen 1 modulatorsMelanoma-associated antigen 3 modulators

TargetsMelanoma-associated antigen 1Melanoma-associated antigen 3

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsMelanoma

ATC CodeN/A